MARC보기
LDR05920cmm u2200733Mu 4500
001000000314709
003OCoLC
00520230525165110
006m d
007cr |n|---|||||
008170930s2017 xx obf 001 0 eng d
019 ▼a 1005690252
020 ▼a 1284151875
020 ▼a 9781284151879 ▼q (electronic bk.)
020 ▼z 9781284124705
020 ▼z 1284124703
035 ▼a 2127200 ▼b (N$T)
035 ▼a (OCoLC)1004984915 ▼z (OCoLC)1005690252
040 ▼a EBLCP ▼b eng ▼e pn ▼c EBLCP ▼d YDX ▼d OCLCO ▼d OCLCQ ▼d OCLCO ▼d OCLCA ▼d N$T ▼d 248032
049 ▼a MAIN
050 4 ▼a RC606.6 ▼b .S29 2017
060 4 ▼a WC 39 ▼b H67377 2017
08204 ▼a 616.9792
1001 ▼a Sax, Paul E.
24510 ▼a HIV Essentials 2017. ▼h [electronic resource]
250 ▼a 8th ed.
260 ▼a Sudbury : ▼b Jones & Bartlett Learning, ▼c 2017.
300 ▼a 1 online resource (652 pages)
336 ▼a text ▼b txt ▼2 rdacontent
337 ▼a computer ▼b c ▼2 rdamedia
338 ▼a online resource ▼b cr ▼2 rdacarrier
500 ▼a Cardiac Complications.
504 ▼a Includes bibliographical references and index.
5050 ▼a Cover Page; Title Page; Copyright Page; Editorial Note; Tables and Figures; Table of Contents; Contributors; Acknowledgements; Notice; Abbreviations for Antiretroviral Agents; Other Abbreviations; 1. Overview of HIV Infection; Overview; Stages of HIV Infection; Acute HIV Infection; Differential Diagnosis; Signs and Symptoms; Laboratory Findings; Diagnostic Testing; Management; 2. Testing for HIV and Baseline Evaluation; HIV Diagnostic Testing; Whom to Test; Testing for HIV; HIV Antibody Tests; Selected Licensed HIV Diagnostic Tests; HIV Viral Load Assays; Uses; Assays and Interpretation.
5058 ▼a IndicationsInitial Assessment of HIV-Infected Patients; Clinical Evaluation; Laboratory Testing; CD4 Cell Count; 3. Treatment of HIV Infection; Initiation of Antiretroviral Therapy; Selection of an Optimal Initial Antiretroviral Regimen; Antiretroviral Therapy Adverse Effects; 4. Management OF the Treatment-Experienced Patient; Antiretroviral Treatment Failure; Virologic Response Definitions; Evaluation of Virologic Failure; Important Genotypic Resistance Patterns; Poor CD4 Recovery Despite Virologic Suppression; Regimen Switching in the Setting of Virologic Suppression (See Table 4-2).
5058 ▼a General Principles of Regimen SwitchingRegimen Switch Strategies in the Setting of Drug Toxicity; 5. Prophylaxis and Treatment of Opportunistic Infections; Prophylaxis of Opportunistic Infections; Treatment of Opportunistic Infections; Aspergillosis, Invasive; Bacterial respiratory Diseases; Bartonella Infections; Campylobacteriosis; Candidiasis (Mucosal); Chagas Disease; Clostridium Difficile Diarrhea/Colitis; Coccidioidomycosis; Cryptococcal Meningitis; Cryptosporidiosis; Cytomegalovirus Disease; Hepatitis B Virus; Hepatitis C Virus; Herpes Simplex Virus Disease; HHV-8 Infection.
5058 ▼a Histoplasma CapsulatumHuman Papillomavirus Disease; Isospora Belli Infection; Leishmaniasis, Cutaneous; Malaria; Microsporidiosis; Mycobaterium Avium Complex Disease; Mycobaterium Tuberculosis; Penicilliosis; Pneumocystis Pneumonia; Progressive Multifocal Leukoencephalopathy; Salmonellosis; Shigellosis; Toxoplasma Gondii Encephalitis; Treponema Pallidum (Syphilis); Varicella-Zoster Virus Disease; 6. Complications of HIV Infection; Hematologic Complications; Thrombocytopenia/anemia; Neutropenia; Eosinophilia; Oncologic Complications; Kaposi's Sarcoma; Non-Hodgkin's Lymphoma.
5058 ▼a Primary CNS LymphomaCervical/Anal Cancer; Endocrine Complications; Adrenal Insufficiency; Hypogonadism; Thyroid Disease; Pancreatitis; Hyperglycemia; Hypoglycemia; Ovarian Complications; Bone Disease; Morphologic Complications of Therapy; Lipoatrophy; Fat Accumulation and Weight Gain; Prevention of Lipodystrophy; Lipid Abnormalities; Gastrointestinal Tract Complications; Anorexia; Nausea/vomiting; Diarrhea; Oral/esophageal ulcers; HIV cholangiopathy; Renal Complications; HIV-Associated; Medication-Related; HCV-Associated; Heroin Nephropathy; Inhibition of Tubular Secretion of Creatinine.
520 ▼a Everything needed to manage HIV patients in the office, on the ward, and in the ICU. Incorporates clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include: opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs.
5880 ▼a Print version record.
590 ▼a Added to collection customer.56279.3
650 0 ▼a HIV (Viruses)
650 0 ▼a HIV (Viruses) ▼v Handbooks, manuals, etc.
650 0 ▼a HIV infections ▼v Handbooks, manuals, etc.
650 0 ▼a Antiretroviral agents ▼v Handbooks, manuals, etc.
65012 ▼a HIV Infections.
65012 ▼a HIV Infections ▼x drug therapy.
65022 ▼a Anti-HIV Agents ▼x therapeutic use.
65022 ▼a Antiretroviral Therapy, Highly Active.
650 7 ▼a Antiretroviral agents. ▼2 fast ▼0 (OCoLC)fst00810765
650 7 ▼a HIV infections. ▼2 fast ▼0 (OCoLC)fst00949871
650 7 ▼a HIV (Viruses) ▼2 fast ▼0 (OCoLC)fst00949837
655 2 ▼a Handbook.
655 4 ▼a Electronic books.
655 7 ▼a Handbooks and manuals. ▼2 fast ▼0 (OCoLC)fst01423877
655 7 ▼a Handbooks and manuals. ▼2 lcgft
7001 ▼a Cohen, Calvin J.
7001 ▼a Kuritzkes, Daniel R.
77608 ▼i Print version: ▼a Sax, Paul E. ▼t HIV Essentials 2017. ▼d Sudbury : Jones & Bartlett Learning, 짤2017 ▼z 9781284124705
85640 ▼3 EBSCOhost ▼u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2127200
938 ▼a EBL - Ebook Library ▼b EBLB ▼n EBL5056899
938 ▼a YBP Library Services ▼b YANK ▼n 14846314
938 ▼a EBSCOhost ▼b EBSC ▼n 2127200
990 ▼a 관리자
994 ▼a 92 ▼b N$T